Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Advanced solid tumors · Advanced Solid Tumors · TTRX

Turn Therapeutics

Turn Therapeutics patent portfolio — 40 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Westlake Village, USA HQ
2015 Founded
11 Employees
Public company Type
TTRX · NYSE Ticker
Company details
Status
Public
HQ
Westlake Village, USA
Founded
2015
Employees
11
Programs
6
Drugs
3
Patents
40
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Turn Therapeutics patents

40 pharmaceutical patents indexed for Turn Therapeutics. 0 expire within 24 months.

Turn Therapeutics has 40 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

40 patents

Patent portfolio

  1. US 12310968

    Chiral diaryl macrocycles and uses thereof

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12252488

    HPK1 antagonists and uses thereof

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12215105

    HPK1 antagonists and uses thereof

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12187739

    Diaryl macrocycle polymorph

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12071442

    Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11981684

    Macrocyclic compounds and uses thereof

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11926625

    HPK1 antagonists and uses thereof

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11802292

    Modified orthopoxvirus vectors

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11666574

    Combination therapy involving diaryl macrocyclic compounds

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11654145

    Combination therapy involving diaryl macrocyclic compounds

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11634433

    Macrocycles for use in treating disease

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11590184

    Oncolytic rhabdovirus expressing IL12

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11548890

    HPK1 antagonists and uses thereof

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11452725

    Chiral diaryl macrocycles and uses thereof

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11291667

    Combination therapy involving diaryl macrocyclic compounds

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11286265

    Macrocyclic compounds for treating disease

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11286264

    Macrocyclic compounds and uses thereof

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11155563

    Macrocyclic compounds and uses thereof

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11142533

    Macrocycles for use in treating disease

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11078201

    Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11034694

    Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11028085

    Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11021481

    Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11008337

    Chiral diaryl macrocycles as modulators of protein kinases

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10925946

    Vaccination methods

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10745416

    Macrocyclic compounds for treating disease

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10689400

    Macrocycle kinase inhibitors

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10660947

    Vaccine composition

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10646557

    Vaccine composition

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10604741

    Compositions and methods for enhancing virus replication

    Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10603351

    Engineered synergistic oncolytic viral symbiosis

    Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10363293

    Vaccine composition

    Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10066214

    Compositions and methods for enhancing virus replication

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9896664

    Oncolytic rhabdovirus

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9821054

    Method of vaccination comprising a histone deacetylase inhibitor

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9707285

    Vaccination methods

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9572883

    Oncolytic rhabdovirus

    Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7073512

    Adhesion prevention and an endoscopic insufflation system therefor

    Expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 6428500

    Adhesion prevention and an endoscopic insufflation system therefor

    Expires Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6248778

    Anticholestatic effect of luteolin

    Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Turn Therapeutics have?

40 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Turn Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.